Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001129 · ClinicalTrials.gov registry record · NA
A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 1,248
- Enrollment target
NCT00001129: Completed NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00001129 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001129, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 1,248 participants
- Enrollment target
Study Summary
The purpose of this study is to look at different ways to help patients follow their anti-HIV medication schedules. It is very important that HIV-positive patients take their anti-HIV medications correctly so they get the best possible benefit from them. Taking the drugs correctly, called "adherence," may keep HIV virus levels in the blood (viral load) low for a longer time. However, anti-HIV medication schedules are often complicated, and many patients have difficulty remembering to take their drugs at the correct time. This study will look at 2 different ways to teach patients about the importance of taking their medications correctly and to remind them when to take their medications.
Interventions
- DEVICE Electronic Medication Reminder System
- BEHAVIORAL Medication Manager
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,248 participants |
| Est. Completion | 2003-06 |
| Phase | NA |
What the finished NCT00001129 record still lists
NCT00001129 is an interventional study that assigns participants to a tested intervention. Its 1,248 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 2 interventions - of which Electronic Medication Reminder System is the first listed.
NCT00001129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001129 about?
NCT00001129 is a clinical study titled "A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly". The purpose of this study is to look at different ways to help patients follow their anti-HIV medication schedules. It is very important that HIV-positive patients take their anti-HIV medications correctly so they get the best possible benefit from them. Taking the drugs correctly, called "adherenc...
What is the current status of trial NCT00001129?
This trial is currently completed. It is a NA study. The enrollment target is 1,248 participants. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00001129?
The interventions under investigation include: Electronic Medication Reminder System (DEVICE), Medication Manager (BEHAVIORAL).
Who is sponsoring clinical trial NCT00001129?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00001129's enrollment target sits among peer trials
1,248 82nd of 2000 higher than 1,919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies